Latest From Hollister Inc.
The latest government filing in a False Claims Act case involving Coloplast counters the defendants’ argument that the case should be dismissed because the alleged kickbacks fell within the "discount" safe harbor.
The settlement puts to bed whistleblower allegations that Hollister paid supplier Byram for encouraging ostomy and continence care patients to use Hollister products. Byram allegedly had similar arrangements with other manufacturers, including Coloplast.
Acquisitions and innovation are rapidly changing the dynamics in the global advanced wound care market, a high need, high growth market estimated at $5.4 billion in 2013. With the number of chronic wounds in major countries estimated at a whopping 26.7 million, the global advanced wound care market is projected to grow at a brisk 6% CAGR, reaching $7.3 billion by 2018.
Floelle Inc. is developing a nonsurgical solution for women with stress and mixed urinary incontinence that it thinks will address the drawbacks of current technologies and provide a safe and effective solution that is convenient for patients. The Floelle device resides in the urethra where it allows normal urination, but a pressure-sensitive valve blocks the involuntary urine leaks caused by coughing, laughing, sneezing, and other activities that increase intra-abdominal pressure in women with stress urinary incontinence.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.